These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31937780)

  • 1. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment.
    Lohard S; Bourgeois N; Maillet L; Gautier F; Fétiveau A; Lasla H; Nguyen F; Vuillier C; Dumont A; Moreau-Aubry A; Frapin M; David L; Loussouarn D; Kerdraon O; Campone M; Jézéquel P; Juin PP; Barillé-Nion S
    Nat Commun; 2020 Jan; 11(1):259. PubMed ID: 31937780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins.
    Long J; Liu L; Nikolovska-Coleska Z; Shangary S; Yi H; Wang S; Wang S
    BMC Biotechnol; 2013 May; 13():45. PubMed ID: 23705845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death.
    Zierhut C; Yamaguchi N; Paredes M; Luo JD; Carroll T; Funabiki H
    Cell; 2019 Jul; 178(2):302-315.e23. PubMed ID: 31299200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics.
    Lohard S; Juin PP; Barillé-Nion S
    Mol Cell Oncol; 2020; 7(3):1735912. PubMed ID: 32391429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.
    Oakes SR; Vaillant F; Lim E; Lee L; Breslin K; Feleppa F; Deb S; Ritchie ME; Takano E; Ward T; Fox SB; Generali D; Smyth GK; Strasser A; Huang DC; Visvader JE; Lindeman GJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2766-71. PubMed ID: 21768359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC Is a Major Determinant of Mitotic Cell Fate.
    Topham C; Tighe A; Ly P; Bennett A; Sloss O; Nelson L; Ridgway RA; Huels D; Littler S; Schandl C; Sun Y; Bechi B; Procter DJ; Sansom OJ; Cleveland DW; Taylor SS
    Cancer Cell; 2015 Jul; 28(1):129-40. PubMed ID: 26175417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells.
    Séveno C; Loussouarn D; Bréchet S; Campone M; Juin P; Barillé-Nion S
    Breast Cancer Res; 2012 Jun; 14(3):R96. PubMed ID: 22703841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-xL controls a switch between cell death modes during mitotic arrest.
    Bah N; Maillet L; Ryan J; Dubreil S; Gautier F; Letai A; Juin P; Barillé-Nion S
    Cell Death Dis; 2014 Jun; 5(6):e1291. PubMed ID: 24922075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified Bcl-2 network model reveals quantitative determinants of cell-to-cell variation in sensitivity to anti-mitotic chemotherapeutics.
    Kueh HY; Zhu Y; Shi J
    Sci Rep; 2016 Nov; 6():36585. PubMed ID: 27811996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway.
    Cheradame L; Guerrera IC; Gaston J; Schmitt A; Jung V; Goudin N; Pouillard M; Radosevic-Robin N; Modesti M; Judde JG; Cairo S; Goffin V
    Oncogene; 2021 Dec; 40(49):6627-6640. PubMed ID: 34625708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial-induced cell fusion is a danger signal triggering cGAS-STING pathway via micronuclei formation.
    Ku JWK; Chen Y; Lim BJW; Gasser S; Crasta KC; Gan YH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15923-15934. PubMed ID: 32571920
    [No Abstract]   [Full Text] [Related]  

  • 13. Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons.
    Tesser A; Piperno GM; Pin A; Piscianz E; Boz V; Benvenuti F; Tommasini A
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
    Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
    Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grifola frondosa polysaccharides induce breast cancer cell apoptosis via the mitochondrial-dependent apoptotic pathway.
    Zhang Y; Sun D; Meng Q; Guo W; Chen Q; Zhang Y
    Int J Mol Med; 2017 Oct; 40(4):1089-1095. PubMed ID: 28765878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAF
    Hartman ML; Gajos-Michniewicz A; Talaj JA; Mielczarek-Lewandowska A; Czyz M
    Cancer Lett; 2021 Feb; 499():122-136. PubMed ID: 33259900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection.
    Storek KM; Gertsvolf NA; Ohlson MB; Monack DM
    J Immunol; 2015 Apr; 194(7):3236-45. PubMed ID: 25710914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.